about
Impaired Spinal Glucocorticoid Receptor Signaling Contributes to the Attenuating Effect of Depression on Mechanical Allodynia and Thermal Hyperalgesia in Rats with Neuropathic Pain.Anxiety- and depression-like behavior and impaired neurogenesis evoked by peripheral neuropathy persist following resolution of prolonged tactile hypersensitivity.Developmental fluoxetine exposure normalizes the long-term effects of maternal stress on post-operative pain in Sprague-Dawley rat offspring.Inflammatory pain and corticosterone response in infant rats: effect of 5-HT1A agonist buspirone prior to gestational stressPhysiologically relevant changes in serotonin resolved by fast microdialysis.Abnormal trigeminal sensory processing in obese mice.Epigallocatechin-3-gallate reduces myometrial infiltration, uterine hyperactivity, and stress levels and alleviates generalized hyperalgesia in mice induced with adenomyosis.Animal model of simulated microgravity: a comparative study of hindlimb unloading via tail versus pelvic suspension.Evaluation of buprenorphine hydrochloride Pluronic(®) gel formulation in male C57BL/6NCrl mice.N/OFQ system in brain areas of nerve-injured mice: its role in different aspects of neuropathic pain.Assessment of the involvement of the macrophage migration inhibitory factor-glucocorticoid regulatory dyad in the expression of matrix metalloproteinase-2 during periodontitis.Controlled dexamethasone delivery via double-walled microspheres to enhance long-term adipose tissue retention.Neuropathic pain drives anxiety behavior in mice, results consistent with anxiety levels in diabetic neuropathy patients.Anxiety Specific Response and Contribution of Active Hippocampal Neural Stem Cells to Chronic Pain Through Wnt/β-Catenin Signaling in Mice
P2860
Q33705029-4B83C8EA-3D2F-4D93-AD1B-80A5A9E942AFQ34162717-3242341C-0B10-4A5A-8875-86E00F622760Q34600630-9732B9E7-80B7-4AEF-96C3-C220E6FB4F82Q36771591-3A975BA3-DCCE-446F-9FB9-6A7A23D4AB98Q36851690-4A6AAD29-F4C8-4514-943D-C1315CB72D35Q37066103-D13939D9-BC0F-4D35-9E59-EED0C5A02C03Q37280178-2BDC6CA4-652B-44C9-A3DE-1C9A7B32500FQ37319458-75EE14EA-A8D8-41A9-BE01-D70676C67099Q37425113-0E1C8AD5-F257-4B5A-9B75-C4D9B292B132Q39078235-63B1CD29-EA10-4A9C-83BF-308B9544D3FCQ40106745-AAD02E92-8408-407C-988E-D8427729FE32Q42375628-5555CB67-E053-4469-B67E-46545CBB2F42Q55369771-28E3BB67-AE04-4500-82CB-95A2EA62AD2FQ58705518-E54A0871-9249-4547-A3B7-05435BCF96B3
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Plasma corticosterone levels in mouse models of pain.
@en
Plasma corticosterone levels in mouse models of pain.
@nl
type
label
Plasma corticosterone levels in mouse models of pain.
@en
Plasma corticosterone levels in mouse models of pain.
@nl
prefLabel
Plasma corticosterone levels in mouse models of pain.
@en
Plasma corticosterone levels in mouse models of pain.
@nl
P2093
P2860
P1476
Plasma corticosterone levels in mouse models of pain.
@en
P2093
M Benedetti
M I Ravanelli
P dos Santos
P2860
P304
P356
10.1002/J.1532-2149.2011.00066.X
P577
2011-12-19T00:00:00Z